Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0001179110-19-013085

VP, Clinical&Translational Sc gave up 281 shares (to pay taxes)

  • VP, Clinical&Translational Sc acquired 1,150 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DeVinney Erick Wayne VP, Clinical&Translational Sc 2019-12-18 Grant or award +1,150 43,121 D
DeVinney Erick Wayne VP, Clinical&Translational Sc 2019-12-18 Shares withheld for taxes −281 $16.73 $4,701 42,840 D
Loading xslF345X03/edgar.xml…